Prostaglandin E2 Impairs P2Y2/P2Y4 Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors

Prostaglandin E 2 (PGE 2 ) is an important bioactive lipid that accumulates after tissue damage or inflammation due to the rapid expression of cyclooxygenase 2. PGE 2 activates specific G-protein coupled EP receptors and it mediates pro- or anti-inflammatory actions depending on the cell-context. Nu...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 8; p. 937
Main Authors Paniagua-Herranz, Lucía, Gil-Redondo, Juan C., Queipo, Ma José, González-Ramos, Silvia, Boscá, Lisardo, Pérez-Sen, Raquel, Miras-Portugal, Ma Teresa, Delicado, Esmerilda G.
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 22.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Prostaglandin E 2 (PGE 2 ) is an important bioactive lipid that accumulates after tissue damage or inflammation due to the rapid expression of cyclooxygenase 2. PGE 2 activates specific G-protein coupled EP receptors and it mediates pro- or anti-inflammatory actions depending on the cell-context. Nucleotides can also be released in these situations and they even contribute to PGE 2 production. We previously described the selective impairment of P2Y nucleotide signaling by PGE 2 in macrophages and fibroblasts, an effect independent of prostaglandin receptors but that involved protein kinase C (PKC) and protein kinase D (PKD) activation. Considering that macrophages and fibroblasts influence inflammatory responses and tissue remodeling, a similar mechanism involving P2Y signaling could occur in astrocytes in response to neuroinflammation and brain repair. We analyzed here the modulation of cellular responses involving P2Y 2 /P2Y 4 receptors by PGE 2 in rat cerebellar astrocytes. We demonstrate that PGE 2 inhibits intracellular calcium responses elicited by UTP in individual cells and that inhibiting this P2Y signaling impairs the astrocyte migration elicited by this nucleotide. Activation of EP3 receptors by PGE 2 not only impairs the calcium responses but also, the extracellular regulated kinases (ERK) and Akt phosphorylation induced by UTP. However, PGE 2 requires epidermal growth factor receptor (EGFR) transactivation in order to dampen P2Y signaling. In addition, these effects of PGE 2 also occur in a pro-inflammatory context, as evident in astrocytes stimulated with bacterial lipopolysaccharide (LPS). While we continue to investigate the intracellular mechanisms responsible for the inhibition of UTP responses, the involvement of novel PKC and PKD in cerebellar astrocytes cannot be excluded, kinases that could promote the internalization of P2Y receptors in fibroblasts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Silvia González-Ramos, Instituto de Investigaciones Biomédicas Alberto Sols, Centro Mixto del Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain Lisardo Boscá, Instituto de Investigaciones Biomédicas Alberto Sols, Centro Mixto del Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain; Departamento de Bioquímica y Biología Molecular IV, Facultad de Veterinaria, Universidad Complutense Madrid, Madrid, Spain
Reviewed by: Tycho Hoogland, Erasmus University Rotterdam, Netherlands; Chuang Wang, Ningbo University, China
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Edited by: Francisco Ciruela, University of Barcelona, Spain
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2017.00937